Trial intelligence / Profile preview

Effect of Moisturizers on Metronidazole Absorption in Rosacea

NCT06434519Completed

Sponsor
Duke University
Start
Sep 2024
Primary completion
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of metronidazole in rosacea (4 arms), sponsored by Duke University. Primary endpoint: Metronidazole penetrance through the stratum corneum (SC) at 4 hours. Started Sep 2024; status: completed.

02

Drugs

metronidazole
03

Conditions

rosacea

Beyond the preview

Go deeper on NCT06434519.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06434519.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call